Literature DB >> 31200118

In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening.

Jéssica Antunes1, Vítor M Gaspar2, Luís Ferreira1, Maria Monteiro1, Rui Henrique3, Carmen Jerónimo3, João F Mano4.   

Abstract

Three-dimensional (3D) in vitro tumor spheroids are becoming popular as pre-clinical platforms for testing the performance of existing drugs or for discovery of innovative anti-cancer therapeutics. This focus is correlated with in vitro 3D tumor models ability to mimic the multicellular compact structure and spatial architecture of human solid tumors. However, these microphysiological systems generally lack the pre-existence of tumor-ECM, a critical aspect that can affect the overall therapeutic performance and the decision of advancing candidate drugs to later stages of the pipeline. Aiming to face this drawback and mimic tumors-ECM, herein we rapidly fabricated in-air hyaluronan-methacrylate (HA-MA) and gelatin-methacrylate (GelMA) photocrosslinkable 3D spheroid microgels by using superhydrophobic surfaces. These platforms were used for establishing heterotypic 3D co-culture models of prostate cancer cells (PC-3) and human osteoblasts (hOB) to mimic prostate cancer-to-bone metastasis cellular heterogeneity and the tumor-ECM microenvironment. 3D microgel microtumors morphology, size and cell number were easily controlled via digital droplet generation on polystyrene superhydrophobic surfaces and under solvent-free conditions when compared to microfluidics or electrospray. Co-culture 3D microgels formed by 2.5%HA-MA-5%GelMA and 5%HA-MA-5%GelMA ratios showed the highest calcium deposition after 14 days of culture, evidencing osteoblasts viability and the establishment of functional mineralization in the 3D hydrogel matrix. Cisplatin cytotoxicity evaluation showed that 3D microgels are more resistant to platin chemotherapeutics than single or co-culture 3D multicellular spheroid counterparts. Overall, our findings indicate that solvent-free, in-air produced 3D microgel microenvironments are cost-effective and robust tumor mimicking platforms for in vitro high-throughput screening of therapeutics targeted to prostate-to-bone metastasis microenvironments. STATEMENT OF SIGNIFICANCE: The generation of robust microphysiological systems that recapitulate the complexity of the metastatic prostate-to-bone tumor microenvironment is crucial for pre-clinical evaluation of new therapeutics that can eradicate these secondary tumors. In this study, we employed superhydrophobic (SH) surfaces to rapidly fabricate photocrosslinkable hyaluronan-methacrylate/gelatin-methacrylate 3D spheroid microgels for prostate cancer cells and human osteoblasts co-culture models that simultaneously mimic the cellular and ECM tumor components. The use of SH platforms overcomes the issues of standard in-liquid microgel production technologies by providing a robust control over 3D microgels size/morphology and cell-cell co-encapsulation numbers, while avoiding the use of oil-based microgel droplets generation. Overall, SH surfaces allowed a solvent-free, cost-effective, reproducible and adaptable fabrication of heterotypic 3D spherical microgels for high throughput drug screening.
Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3D in vitro tumor models; Drug screening; Spherical microgels; Superhydrophobic surface

Mesh:

Substances:

Year:  2019        PMID: 31200118     DOI: 10.1016/j.actbio.2019.06.012

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  9 in total

Review 1.  Proteinaceous Hydrogels for Bioengineering Advanced 3D Tumor Models.

Authors:  Barbara Blanco-Fernandez; Vítor M Gaspar; Elisabeth Engel; João F Mano
Journal:  Adv Sci (Weinh)       Date:  2021-01-04       Impact factor: 16.806

Review 2.  Fabrication approaches for high-throughput and biomimetic disease modeling.

Authors:  Mackenzie L Grubb; Steven R Caliari
Journal:  Acta Biomater       Date:  2021-03-11       Impact factor: 10.633

3.  Synthesis and Physicochemical Characterization of Undecylenic Acid Grafted to Hyaluronan for Encapsulation of Antioxidants and Chemical Crosslinking.

Authors:  Gloria Huerta-Ángeles; Martina Brandejsová; Kateřina Kopecká; František Ondreáš; Tomáš Medek; Ondrej Židek; Jaromír Kulhánek; Hana Vagnerová; Vladimir Velebný
Journal:  Polymers (Basel)       Date:  2019-12-24       Impact factor: 4.329

Review 4.  Reductionist Three-Dimensional Tumor Microenvironment Models in Synthetic Hydrogels.

Authors:  Rachel R Katz; Jennifer L West
Journal:  Cancers (Basel)       Date:  2022-02-26       Impact factor: 6.639

5.  Controlled release of silibinin in GelMA hydrogels inhibits inflammation by inducing M2-type macrophage polarization and promotes vascularization in vitro.

Authors:  Weijian Xu; Yingjia Sun; Jia Wang; Baixiang Wang; Fanxing Xu; Zhijian Xie; Yu Wang
Journal:  RSC Adv       Date:  2022-05-03       Impact factor: 4.036

6.  Preparation of Vancomycin-Loaded Aerogels Implementing Inkjet Printing and Superhydrophobic Surfaces.

Authors:  Patricia Remuiñán-Pose; Clara López-Iglesias; Ana Iglesias-Mejuto; Joao F Mano; Carlos A García-González; M Isabel Rial-Hermida
Journal:  Gels       Date:  2022-07-04

7.  Recent advances in 3D models of tumor invasion.

Authors:  Della S Shin; Kristi S Anseth
Journal:  Curr Opin Biomed Eng       Date:  2021-06-08

Review 8.  Applications of Gelatin Methacryloyl (GelMA) Hydrogels in Microfluidic Technique-Assisted Tissue Engineering.

Authors:  Taotao Liu; Wenxian Weng; Yuzhuo Zhang; Xiaoting Sun; Huazhe Yang
Journal:  Molecules       Date:  2020-11-13       Impact factor: 4.411

9.  Investigation on the Composition of Agarose-Collagen I Blended Hydrogels as Matrices for the Growth of Spheroids from Breast Cancer Cell Lines.

Authors:  Alessandra Quarta; Nunzia Gallo; Daniele Vergara; Luca Salvatore; Concetta Nobile; Andrea Ragusa; Antonio Gaballo
Journal:  Pharmaceutics       Date:  2021-06-26       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.